Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Guglielmo Borgia

Showing results (1-10 of 104) with videos related to

Pageof 11
Sort By:
Current Opinion in Investigational Drugs (London, England : 2000)|December 17, 2004
HepeX-C (XTL Biopharmaceuticals)Guglielmo Borgia
Idrugs : the Investigational Drugs Journal|June 16, 2004
Specific immunoglobulin against HCV: new perspectivesGuglielmo Borgia
The Lancet. Infectious Diseases|April 13, 2015
A pill a day keeps HCV awayIvan Gentile, Guglielmo Borgia
International Journal of Women'S Health|June 27, 2014
Vertical transmission of hepatitis B virus: challenges and solutionsIvan Gentile, Guglielmo Borgia
Journal of Hepatology|March 30, 2010
Surrogate endpoints and non-inferiority trials in chronic viral hepatitisIvan Gentile, Guglielmo Borgia
Expert Review of Anti-Infective Therapy|August 11, 2010
Development and progression of gastroesophageal varices in patients with chronic hepatitis CIvan Gentile, Guglielmo Borgia
Evidence-Based Medicine|July 17, 2014
Ledipasvir/Sofosbuvir administration achieves very high rate of viral clearance in patients with HCV genotype 1 infection without cirrhosis, regardless of ribavirin co-administration or length of treatmentIvan Gentile, Guglielmo Borgia
Hepatology (Baltimore, Md.)|October 16, 2004
Immune system homeostasis during acute hepatitis C: viral escape or T-cell regulation?Alessandro Perrella, Guglielmo Borgia, Oreste Perrella
BMC Infectious Diseases|March 9, 2010
Is the drug-induced hypersensitivity syndrome (DIHS) due to human herpesvirus 6 infection or to allergy-mediated viral reactivation? Report of a case and literature reviewIvan Gentile, Maria Talamo, Guglielmo Borgia
Translational Gastroenterology and Hepatology|December 22, 2017
Direct acting antiviral agents and hepatocellular carcinoma development: don't take it for grantedAntonio Riccardo Buonomo, Ivan Gentile, Guglielmo Borgia
Pageof 11

Showing results (1-10 of 104) with videos related to

Sort By:
Pageof 11
Current Opinion in Investigational Drugs (London, England : 2000)|December 17, 2004
HepeX-C (XTL Biopharmaceuticals)Guglielmo Borgia
Idrugs : the Investigational Drugs Journal|June 16, 2004
Specific immunoglobulin against HCV: new perspectivesGuglielmo Borgia
The Lancet. Infectious Diseases|April 13, 2015
A pill a day keeps HCV awayIvan Gentile, Guglielmo Borgia
International Journal of Women'S Health|June 27, 2014
Vertical transmission of hepatitis B virus: challenges and solutionsIvan Gentile, Guglielmo Borgia
Journal of Hepatology|March 30, 2010
Surrogate endpoints and non-inferiority trials in chronic viral hepatitisIvan Gentile, Guglielmo Borgia
Expert Review of Anti-Infective Therapy|August 11, 2010
Development and progression of gastroesophageal varices in patients with chronic hepatitis CIvan Gentile, Guglielmo Borgia
Evidence-Based Medicine|July 17, 2014
Ledipasvir/Sofosbuvir administration achieves very high rate of viral clearance in patients with HCV genotype 1 infection without cirrhosis, regardless of ribavirin co-administration or length of treatmentIvan Gentile, Guglielmo Borgia
Hepatology (Baltimore, Md.)|October 16, 2004
Immune system homeostasis during acute hepatitis C: viral escape or T-cell regulation?Alessandro Perrella, Guglielmo Borgia, Oreste Perrella
BMC Infectious Diseases|March 9, 2010
Is the drug-induced hypersensitivity syndrome (DIHS) due to human herpesvirus 6 infection or to allergy-mediated viral reactivation? Report of a case and literature reviewIvan Gentile, Maria Talamo, Guglielmo Borgia
Translational Gastroenterology and Hepatology|December 22, 2017
Direct acting antiviral agents and hepatocellular carcinoma development: don't take it for grantedAntonio Riccardo Buonomo, Ivan Gentile, Guglielmo Borgia
Pageof 11